CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Shanghai Shenqi Pharmactcl Inv Mgt CoLtd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Shanghai Shenqi Pharmactcl Inv Mgt CoLtd
Room 613
Changfa Tower, No. 128, Weihai Road
Phone: +86 2153750009p:+86 2153750009 SHANGHAI, SHA  200003  China Ticker: 600613600613
Business Summary
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd is a China-based company primarily engaged in the research, development, production and sales of pharmaceuticals. The Company's products cover therapeutic areas such as anti-tumor, cold and cough, cardiovascular and cerebrovascular, rheumatic and bone pain, antifungal, tonic and tranquilizing, and gynecological. The Company’s main products include sodium cantharidinate and vitamin B6 injection, sodium cantharidinate injection, loquat cough granules, strong loquat dew, loquat cough capsules, Jinwu Gutong capsules, Shanhu Xuanjing, Jingwu capsules, Quantianma capsules, and Yindan Xintai dripping pills. The Company distributes its products within the domestic market and to overseas markets.
(Source: ARS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202512/31/2024Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
5122 Drugs, drug proprietaries, and druggists' sundries

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board ZhitingZhang 6/26/2020
Vice Chairman of the Board TaotaoZhang 42 6/26/2020 6/30/2006
Chief Financial Officer FamiaoLi 6/26/2020 6/26/2020
7 additional Officers and Directors records available in full report.

Business Names
Business Name
600613
900904
GUIZHOU GUANG DE LI PHARMACEUTICALS
Shanghai Wingsung Data Tech Co. Ltd.

General Information
Number of Employees: 1,266 (As of 12/31/2024)
Outstanding Shares: 534,071,628 (As of 6/30/2025)
Shareholders: 55,220
Stock Exchange: SHA
Fax Number: +86 2153750010


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, October 31, 2025